Successful Rituximab Treatment for Lymphoma, Secondary Immunodeficiency Causing Debilitating Sinusitis: Underlying Primary Immunodeficiency Disease, and Alternative Treatments to Improve the Quality of Life?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Immunology"
DOI: 10.1007/s10875-019-00636-1
Abstract: The Letter to the Editor by Dr. Palmeira et al. in this issue of the Journal of Clinical Immunology brings up several challenges for clinical immunologists who care for patients with secondary immunodeficiency disease caused… read more here.
Keywords: rituximab; immunodeficiency; secondary immunodeficiency; disease ... See more keywords
Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2021-0313
Abstract: Most primary immunodeficiency diseases, and select secondary immunodeficiency diseases, are treated with immunoglobulin (IG) therapy, administered intravenously or subcutaneously (SCIG). The first instance of IG replacement for primary immunodeficiency disease was a 16.5% formulation administered… read more here.
Keywords: overview subcutaneous; immunodeficiency diseases; secondary immunodeficiency; immunodeficiency ... See more keywords
Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2022-0142
Abstract: Aim: Patients with secondary immunodeficiency (SID) are at increased risk of infections and may be treated with immunoglobulin replacement therapy (IgRT). Despite growing efficacy evidence for IgRT in infection prevention in SID, treatment guidelines are… read more here.
Keywords: patients risk; igpro10; secondary immunodeficiency; risk infections ... See more keywords
Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2019.00586
Abstract: Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological manifestations, such as peripheral cytopenias or lymphoproliferative syndromes. Early diagnosis and management have significant prognostic implications. Secondary immunodeficiencies (SID) may also be… read more here.
Keywords: diagnosis; diagnosis management; secondary immunodeficiency; warning signs ... See more keywords
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2022.933983
Abstract: Since the end of 2019, the world has been challenged by the coronavirus disease 2019 (COVID-19) pandemic. With COVID-19 cases rising globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, resulting in the… read more here.
Keywords: emerging sars; identifying markers; markers emerging; secondary immunodeficiency ... See more keywords